New study into hormones' effect on the female voice
Posted on Tuesday 21 February 2006
Tracking the detail of how vocal folds vibrate is the basic approach adopted in this work
Professor David Howard
This new study will also look into what influence an oral contraceptive pill has on the vocal quality of professional female voice users throughout the menstrual cycle. Initial results of an earlier study by the same research team indicated that a particular combined contraceptive pill could help to improve female opera singers' performances. It not only reduced the fluctuations in sexual hormones often responsible for voice problems during the natural menstrual cycle (leading to hoarseness, fatigue and voice loss), but also seems to have eliminated water retention and stabilised the quality of the voice.
Now, funding from the White Rose University Consortium's Capacity Building Grant scheme is helping the research team to explore the impact of the oral contraceptive pill on other professional voice users, such as female teachers, actresses, TV/radio presenters, and singers of other genres (jazz and musical theatre).
Dr Filipa Lä, a Research Fellow, in Sheffield's Department of Music said: "We want to raise awareness among female professional voice users of the effects of sexual hormones on their working capacities, and how to prevent possible long-term voice damage. We are interested in contacting women who use their voices professionally and who have noticed vocal changes related to their menstrual cycle."
Professor David Howard, of the University of York's Department of Electronics, added: "Our voice production mechanism is essentially invisible and it is only fairly recently that we have had the ability to analyse what is actually happening in some detail. Tracking the detail of how vocal folds vibrate is the basic approach adopted in this work, and it has served to confirm the conclusions in relation to this contraceptive pill."
Notes to editors:
- Female professional voice users interested in taking part in the study should contact Dr Filipa Lä, at the University of Sheffield on f.m.la@sheffield.ac.uk
- White Rose University Consortium
The White Rose University Consortium is a strategic partnership between the Universities of Leeds, Sheffield and York. Its role is to secure funding and resources for research, teaching and enterprise activities through effective collaboration. Widely regarded as the UK's leading university partnership and cited by Government as a model of excellence in collaboration, it has attracted some £55 million external funding to the White Rose universities. www.whiterose.ac.uk - Capacity Building Grants for Knowledge Transfer to Industry (Bioscience & Health) Grants are available for a wide range of collaborative activities whose result will be an increase in R&D related investment by companies in the White Rose Universities. Further information from Adam Getliff (Leeds) 0113 3437382, Barry Timmins (0114 222 1054) John McAvoy (York) 01904 435286.
- For further information or to arrange a media interview please contact Danielle Reeves in the University of Sheffield's press office on 0114 222 5339 or email d.reeves@sheffield.ac.uk